Stroke Proteomics: From Discovery to Diagnostic and Therapeutic Applications.

Journal Article (Journal Article;Review)

Stroke remains a leading cause of death and disability, with limited therapeutic options and suboptimal tools for diagnosis and prognosis. High throughput technologies such as proteomics generate large volumes of experimental data at once, thus providing an advanced opportunity to improve the status quo by facilitating identification of novel therapeutic targets and molecular biomarkers. Proteomics studies in animals are largely designed to decipher molecular pathways and targets altered in brain tissue after stroke, whereas studies in human patients primarily focus on biomarker discovery in biofluids and, more recently, in thrombi and extracellular vesicles. Here, we offer a comprehensive review of stroke proteomics studies conducted in both animal and human specimen and present our view on limitations, challenges, and future perspectives in the field. In addition, as a unique resource for the scientific community, we provide extensive lists of all proteins identified in proteomic studies as altered by stroke and perform postanalysis of animal data to reveal stroke-related cellular processes and pathways.

Full Text

Duke Authors

Cited Authors

  • Hochrainer, K; Yang, W

Published Date

  • April 15, 2022

Published In

Volume / Issue

  • 130 / 8

Start / End Page

  • 1145 - 1166

PubMed ID

  • 35420912

Pubmed Central ID

  • PMC9015233

Electronic International Standard Serial Number (EISSN)

  • 1524-4571

Digital Object Identifier (DOI)

  • 10.1161/CIRCRESAHA.122.320110


  • eng

Conference Location

  • United States